REMEDIUM LIFECARE
|
The Current P/E Ratio of REMEDIUM LIFECARE is -32.91.
| Share Price | ₹0.8 | Jan 13,2026 |
| Market Cap | ₹71.4 Cr | |
| Earnings-TTM | ₹-2.2 Cr | TTM-Standalone Results |
| Price/Earnings | -32.91x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of REMEDIUM LIFECARE
Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹71.4 Cr] as on Jan 13,2026
(/) Earnings [ ₹-2.2 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ -32.91x ]
P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.
Thus, for REMEDIUM LIFECARE , the investors are currently willing to pay -32.91 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of REMEDIUM LIFECARE !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of REMEDIUM LIFECARE over the last five years.
Thus, for REMEDIUM LIFECARE , the investors are currently willing to pay -32.91 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of REMEDIUM LIFECARE !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of REMEDIUM LIFECARE over the last five years.
Historical PE (Price/Earnings) ratio chart of REMEDIUM LIFECARE
PE Ratio Performance Analysis for REMEDIUM LIFECARE
- REMEDIUM LIFECARE 's latest p/e ratio is -32.91x.
- REMEDIUM LIFECARE 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 24.05x.
- REMEDIUM LIFECARE 's operated at median p/e ratio of 32.97x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, REMEDIUM LIFECARE 's p/e ratio peaked in Mar2022 at 46.26x.
- REMEDIUM LIFECARE 's p/e ratio hit its five-year low in Mar2023 of 1.75x.
- REMEDIUM LIFECARE 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 24.05x.
- REMEDIUM LIFECARE 's operated at median p/e ratio of 32.97x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, REMEDIUM LIFECARE 's p/e ratio peaked in Mar2022 at 46.26x.
- REMEDIUM LIFECARE 's p/e ratio hit its five-year low in Mar2023 of 1.75x.
How does REMEDIUM LIFECARE 's P/E Ratio benchmark against top 10 peers in Trading Industry?
| Peer Comparison (Trading Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| REMEDIUM LIFECARE | -2.17 | -32.91 | 71.4 |
| ADANI ENTERPRISES LTD | 8,253.33 | 33.80 | 278,922.0 |
| REDINGTON LTD | 1,903.88 | 11.20 | 21,330.7 |
| MMTC LTD | 170.02 | 56.13 | 9,543.0 |
| HONASA CONSUMER LTD | 131.56 | 71.72 | 9,435.7 |
| LLOYDS ENTERPRISES LTD | 355.27 | 25.73 | 9,142.5 |
| ENTERO HEALTHCARE SOLUTIONS LTD | 127.70 | 41.60 | 5,312.7 |
| OPTIEMUS INFRACOM LTD | 67.86 | 60.82 | 4,127.1 |
| POLO QUEEN INDUSTRIAL & FINTECH LTD | 2.70 | 373.61 | 1,007.3 |
| MSTC LTD | 423.03 | 7.92 | 3,350.3 |
| SG MART LTD | 120.03 | 35.91 | 4,309.8 |
Trading Industry Benchmark (Top 10) PE Analysis vs REMEDIUM LIFECARE 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | -32.91x |
| Max industry PE | 373.61x |
| Median industry PE | 35.91x |
| Average industry PE | 62.32x |
You may also like the below Video Courses
